|
PPAPDC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72844999999366E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.8777999999674E-06 |
| Normal-vs-Stage2 |
1.935820E-02 |
| Normal-vs-Stage3 |
2.052300E-02 |
| Normal-vs-Stage4 |
6.862900E-03 |
| Stage1-vs-Stage2 |
4.324800E-01 |
| Stage1-vs-Stage3 |
7.331800E-01 |
| Stage1-vs-Stage4 |
5.075900E-02 |
| Stage2-vs-Stage3 |
7.365400E-01 |
| Stage2-vs-Stage4 |
4.577600E-02 |
| Stage3-vs-Stage4 |
1.242170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78130999999304E-05 |
| Normal-vs-AfricanAmerican |
1.046780E-04 |
| Normal-vs-Asian |
2.553500E-04 |
| Caucasian-vs-AfricanAmerican |
9.141200E-01 |
| Caucasian-vs-Asian |
2.210400E-01 |
| AfricanAmerican-vs-Asian |
1.625550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.17940000002415E-06 |
| Normal-vs-Female |
9.677800E-03 |
| Male-vs-Female |
1.228400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.100100E-03 |
| Normal-vs-Extreme_Weight |
5.41140000032136E-07 |
| Normal-vs-Obese |
6.166800E-04 |
| Normal-vs-Extreme_Obese |
4.418100E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.717960E-01 |
| Normal_Weight-vs-Obese |
6.635800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.639200E-01 |
| Extreme_Weight-vs-Obese |
3.801200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.628400E-01 |
| Obese-vs-Extreme_Obese |
7.587200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.595900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.519470E-03 |
| Normal-vs-Age(61-80Yrs) |
2.94779999998607E-06 |
| Normal-vs-Age(81-100Yrs) |
1.678140E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.650600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.959200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.573600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.132100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.389000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.564200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.42040000000932E-06 |
| Normal-VS-Type2 PRCC |
1.801880E-03 |
| Normal-VS-KIRP CIMP |
6.337700E-02 |
| Normal-VS-Unclassified PRCC |
5.407200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.519600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.318600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.755000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.293600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.072600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.036000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.383700E-04 |
| Normal-vs-N1 |
1.561310E-03 |
| Normal-vs-N2 |
4.05509999999998E-05 |
| N0-vs-N1 |
5.019200E-01 |
| N0-vs-N2 |
7.144200E-02 |
| N1-vs-N2 |
1.973050E-01 |
|
|
